CARAVITA, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.471
NA - Nord America 838
AS - Asia 134
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
Totale 5.453
Salva come PNG Salva come JPEG
Nazione #
IE - Irlanda 2.890
GB - Regno Unito 919
US - Stati Uniti d'America 786
FR - Francia 272
IT - Italia 262
SE - Svezia 72
CN - Cina 54
CA - Canada 52
SG - Singapore 43
DE - Germania 23
KR - Corea 16
IN - India 14
FI - Finlandia 8
BG - Bulgaria 5
EU - Europa 5
RU - Federazione Russa 5
ES - Italia 4
NL - Olanda 4
BR - Brasile 3
JP - Giappone 3
IR - Iran 2
NO - Norvegia 2
AT - Austria 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
ID - Indonesia 1
IL - Israele 1
LU - Lussemburgo 1
RO - Romania 1
UA - Ucraina 1
Totale 5.453
Salva come PNG Salva come JPEG
Città #
Dublin 2.861
Southend 840
Princeton 171
Chandler 90
Altamura 70
New York 63
Ashburn 58
Toronto 50
Washington 48
Fairfield 45
Wilmington 44
Dalmine 34
Ogden 27
London 25
Seoul 16
Bergamo 15
Milan 14
Norwalk 13
Shenzhen 13
Pune 12
Guangzhou 11
Woodbridge 11
Andover 10
San Diego 10
Cambridge 9
Shanghai 9
Chiswick 7
Hounslow 7
Kilburn 7
Hangzhou 6
Prescot 5
Sofia 5
Sorbolo 5
Amsterdam 4
Chicago 4
Helsinki 4
Lappeenranta 4
Mountain View 4
Naples 4
New Bedfont 4
Acton 3
Anacapri 3
Ann Arbor 3
Frankfurt am Main 3
Padova 3
Piacenza 3
Ribeirão Preto 3
St Petersburg 3
Atlanta 2
Beijing 2
Bremen 2
Buccheri 2
Carobbio degli Angeli 2
Catania 2
Houston 2
Islington 2
Madrid 2
Mugnano di Napoli 2
Ningbo 2
Rome 2
Seattle 2
Sesto Fiorentino 2
Southwark 2
Stuttgart 2
Wandsworth 2
Ancona 1
Boardman 1
Bologna 1
Borno 1
Bucharest 1
Bussero 1
Böblingen 1
Carrara 1
Casalmaggiore 1
Casavatore 1
Chennai 1
Chiyoda-ku 1
Cormano 1
Delhi 1
Duelmen 1
Eagle Mountain 1
Esslingen am Neckar 1
Foshan 1
Genoa 1
Greenwich 1
Haikou 1
Hamburg 1
Hitchin 1
Jakarta 1
Jerusalem 1
La Paz 1
Lissone 1
Locate di Triulzi 1
Luxembourg 1
Mainz 1
Messina 1
Moscow 1
Mostoles 1
Nagold 1
Nanping 1
Totale 4.732
Salva come PNG Salva come JPEG
Nome #
Do the remodeling effects of sacubitril/valsartan treatment depend upon heart failure duration? 103
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 94
Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization 93
Systemic Sclerosis and Pulmonary Hypertension: The Great Masquerader 92
Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure with Preserved Ejection Fraction 90
The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation 88
The right side of the circulation in not secondary heart failure with preserved ejection fraction: an elephant in the room? 87
Impact of COVID-19 on exercise pathophysiology: A combined cardiopulmonary and echocardiographic exercise study 86
Pulmonary arterial hypertension associated with a von Hippel-Lindau gene mutation 86
Reply to: ‘The hyperdynamic circulatory profile of patients with COVID-19-related acute vascular distress syndrome’ 85
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: A meta-analysis 82
Assessment of left ventricular diastolic function by three-dimensional transthoracic echocardiography 82
Proposta di una lettera di dimissione standardizzata dopo ospedalizzazione per embolia polmonare acuta 81
Diagnostic and therapeutic models for the management of acute pulmonary embolism: An issue of local available resources 80
Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore 80
Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes 79
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component 77
Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities 76
Ischemic changes in exercise ECG in a hypertensive subject acutely exposed to high altitude. Possible role of a high-altitude induced imbalance in myocardial oxygen supply-demand 76
Exercise stress echocardiography of the pulmonary circulation and right ventricular-arterial coupling in healthy adolescents 75
Ambulatory Blood Pressure in Untreated and Treated Hypertensive Patients at High Altitude: The High Altitude Cardiovascular Research-Andes Study 75
Upward shift and steepening of the blood pressure response to exercise in hypertensive subjects at high altitude 75
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 74
Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure with Preserved Ejection Fraction? 74
Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure 74
Blood pressure response to six-minute walk test in hypertensive subjects exposed to high altitude: Effects antihypertensive combination treatment 74
Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database 73
Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component 73
ANMCO Position paper: Pulmonary circulation diseases and COVID-19 72
Blood pressure at high altitude: Physiology and clinical implications 71
Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps project 71
Statement ANMCO: Tromboembolismo arterioso e venoso: quali implicazioni per la pratica clinica? 70
Recent advances in multimodality imaging of the tricuspid valve 70
Decreased pulmonary vascular distensibility in adolescents conceived by in vitro fertilization 69
Central sleep apnea during continuous positive airway pressure therapy in obstructive sleep apnea patients: From the compliance to adaptation, maladaptation and reflexes 69
Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test 69
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison 69
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 69
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 68
Stiff left atrial syndrome after low-dose radiotherapy for right breast cancer: The need for invasive hemodynamics at exercise 67
Blood pressure response in miners exposed to chronic intermittent hypoxia in Chile 67
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 66
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude 66
Hyperparathyroidism in celiac disease: always secondary? 66
Pulmonary vascular function and exercise capacity in black sub-Saharan Africans 65
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 65
Pulmonary arterial hypertension 63
Noninvasive versus invasive pressure–flow relationship of the pulmonary circulation: Bias and error 63
Heart failure and sleep related breathing disorders: Data from PROMISES (Progetto Multicentrico Italiano Sonno e Scompenso Cardiaco) study 62
Heart failure with preserved ejection fraction and COVID-19: which comes first, the chicken or the egg? Letter regarding the article ‘Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings’ 62
Phenotyping long COVID 62
Hemodynamic phenotyping of pulmonary hypertension in left heart failure 61
Heart failure and anemia: Effects on prognostic variables 61
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects 61
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure 60
Understanding mechanisms of Fontan failure: exercise haemodynamics to unmask diastolic dysfunction, again! 59
Obstructive Ventilatory Disorder in Heart Failure—Caused by the Heart or the Lung? 57
Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease 57
Haemodynamic validation of the three-step HFA-PEFF algorithm to diagnose heart failure with preserved ejection fraction 56
Association of outcome with left ventricular volumes and ejection fraction measured with two- and three-dimensional echocardiography in patients referred for routine, clinically indicated studies 53
Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta-analysis 52
CPET for Long COVID-19 51
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 51
Ipertensione polmonare pre-capillare o post-capillare? Il ruolo dei test provocativi in sala di emodinamica = Pulmonary hypertension: pre- or post-capillary? The role of provocative tests in the cath lab 49
Right Heart Adaptation to Exercise in Pulmonary Hypertension: An Invasive Hemodynamic Study 47
Impact of correcting the 2D PISA method on the quantification of functional tricuspid regurgitation severity 47
An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease 47
The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension 46
Corrigendum to “Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database” [Int J Cardiol. 2020 Oct 15; 317: 103–110. PMID: 32360652] (International Journal of Cardiology (2020) 317 (103–110), (S0167527320312663), (10.1016/j.ijcard.2020.04.079)) 46
Impact of COVID-19 lockdown on exercise capacity in PAH patients 45
Takayasu arteritis with aortic coarctation and multiple stenosis of aortic branches 45
Blood pressure and high altitude: physiological response and clinical management 45
Right heart chambers geometry and function in patients with the atrial and the ventricular phenotypes of functional tricuspid regurgitation 45
The Conundrum of HFpEF Definition: Non-Invasive Assessment Uncertainties and Alternative Diagnostic Strategies 44
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 44
Shedding Light on Latent Pulmonary Vascular Disease in Heart Failure With Preserved Ejection Fraction 44
Management of anticoagulant therapy in the follow-up of pulmonary embolism in clinical practice 43
Incremental Value of Right Atrial Strain Analysis to Predict Atrial Fibrillation Recurrence after Electrical Cardioversion 43
The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 43
Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation 42
Interatrial Shunt Devices 42
Why Do Exercise Hemodynamics Matter? 42
Sildenafil therapy for interferon-β-1a-induced pulmonary arterial hypertension: A case report 41
Clinical Value of a Novel Three-Dimensional Echocardiography–Derived Index of Right Ventricle–Pulmonary Artery Coupling in Tricuspid Regurgitation 41
Corrigendum to 'Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps Project' [Respir. Physiol. Neurobiol. 188, (2013), 223-228] 40
Pick Your Threshold: A Comparison Among Different Methods of Anaerobic Threshold Evaluation in Heart Failure Prognostic Assessment 40
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 39
Pulmonary arterial hypertension-associated genetic variants in combined post-capillary and pre-capillary pulmonary hypertension: a case report 38
Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea 38
Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction 38
Personalized exercise prescription as a tool for hypertension management and cardiovascular prevention: Evidence and pending issues 37
Alterations of cardiovascular complexity during acute exposure to high altitude: A multiscale entropy approach 34
Exercise in hypoxia: a model from laboratory to on-field studies 8
Corrigendum: The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 8
Pulmonary Hypertension Associated with Left Heart Disease 5
null 3
Totale 5.763
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.918
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/20221.433 79 300 213 14 120 179 90 58 83 96 154 47
2022/2023882 179 133 168 81 28 43 26 58 44 17 77 28
2023/20243.430 47 53 101 68 87 711 2.216 86 56 5 0 0
Totale 5.763